PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Bantam Pharmaceutical, LLC

USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bantam ranks #30,962 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.

#30,962
of 49,997 US assignees by volume
Top 38%
by Innovation Score (39.7/100)
25.4
avg claims per patent
+400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30962 · US Corporation #30,962 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 8 grants
  • MID-PACK #30,962/49,997
  • PHOTO-FINISH Bala Bangles
  • CPC-NARROW A61K · 4 areas
  • INNOV-THIN 39.7/100
  • CLAIMS-DENSE 25.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +400% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bala Bangles, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bantam’s 39.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bantam

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bantam's Innovation Score is 39.7/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bantam?

Each dot is one of Bantam’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bantam’s own 25.4 claims/patent is ABOVE the 16.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bantam vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.088.1 010203040 Granted patents (volume) Avg claims / patent Bala Bangles, Inc. - 8, 1Bala BanglesBalmoral Comtec Limited - 8, 16.38Balmoral ComtecBanco Bilbao Vizcaya Argentaria, S.A. - 8, 12.88Banco Bilbao Vizc…Banner Health - 8, 16.88Banner HealthBardy Technologies, Inc. - 8, 16.5BardyBaron Services, Inc. - 8, 16.38Baron ServicesBarry Callebaut AG - 8, 8.25Barry CallebautBasilea Pharmaceutica International AG - 8, 31.62Basilea Pharmaceu…Bantam Pharmaceutical, LLC - 8, 25.38Bantam Pharmaceut…
Bantam vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bantam's grants concentrate

Bantam Pharmaceutical, LLC is a focused PatentsView assignee: 4 CPC subclasses with 87.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). By volume, Bantam sits between Bala Bangles, Inc. and Basilea Pharmaceutica International AG.

Bantam's three-year grant acceleration

Bantam Pharmaceutical, LLC shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Bantam's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Bantam holds 8 patents at rank #31,031, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Bantam

By rank, the assignees closest to #31,031 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Bantam's primary technology class.

Bantam's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 38% higher than 62% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2016202020212022202320242025 2
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Bantam Pharmaceutical, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 12.5%
2020 1 12.5%
2021 1 12.5%
2022 1 12.5%
2023 1 12.5%
2024 1 12.5%
2025partial year 2 25.0%

Which technologies does Bantam Pharmaceutical, LLC patent most?

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bantam Pharmaceutical, LLC's patent record in context - here's where to go next.

  • Bantam Pharmaceutical, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 87.5% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #30,962 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Bantam Pharmaceutical, LLC against Bala Bangles, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.